Literature DB >> 9764138

Stress and coping in early psychosis. Role of symptoms, self-efficacy, and social support in coping with stress.

E M Macdonald1, S Pica, S Mcdonald, R L Hayes, A J Baglioni.   

Abstract

BACKGROUND: Although coping with stress is important in early psychosis, little is known about how this population copes with the range of stressors they encounter in their daily life. This study aims to identify how people with early psychosis cope with a range of stressful situations and to identify what factors might influence their use of coping strategies.
METHOD: Participants included a clinical group of 50 people with early psychosis and a non-clinical group of 22 people matched on age and gender. Data were obtained on symptomatology and social support for the clinical group, and stress and coping, and self-efficacy for all participants.
RESULTS: The clinical group reported coping less well than the non-clinical group and they most commonly used emotion-focused coping. For the clinical group, effective coping correlated with less severe negative symptoms, greater perceived self-efficacy, social support and greater use of problem-focused coping. Self-efficacy and social support predicted increased frequency of the use of problem-focused coping.
CONCLUSION: People with early psychosis who have greater feelings of self-efficacy and perceived social support, and the flexible use of problem-focused coping strategies, appear to be more likely to cope with day-to-day stressors.

Entities:  

Mesh:

Year:  1998        PMID: 9764138

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  11 in total

Review 1.  Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.

Authors:  P T Yanos; R H Moos
Journal:  Clin Psychol Rev       Date:  2006-02-09

2.  Capturing coping with symptoms in people with a diagnosis of schizophrenia: introducing the MACS-24.

Authors:  Maarten Bak; Philippe Delespaul; Lydia Krabbendam; Karola Huistra; Wil Walraven; Jim van Os
Journal:  Int J Methods Psychiatr Res       Date:  2009       Impact factor: 4.035

3.  Exposure to Political Violence in Northern Ireland and Outcome of First Episode Psychosis.

Authors:  Aidan Turkington; Michael Duffy; Suzanne Barrett; Rosalind McCaul; Richard Anderson; Stephen J Cooper; Teresa Rushe; Ciaran Mulholland
Journal:  Schizophr Bull       Date:  2015-10-31       Impact factor: 9.306

4.  Consumer factors predicting level of treatment response to illness management and recovery.

Authors:  Dominique A White; Alan B McGuire; Lauren Luther; Adrienne I Anderson; Peter Phalen; John H McGrew
Journal:  Psychiatr Rehabil J       Date:  2017-09-14

5.  Coping strategies and social support in old age psychosis.

Authors:  Katherine Berry; Christine Barrowclough; Jane Byrne; Nitin Purandare
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-28       Impact factor: 4.328

6.  Social networks of people with dual diagnosis: the quantity and quality of relationships at different stages of substance use treatment.

Authors:  Elspeth M MacDonald; Marni Luxmoore; Simone Pica; Chris Tanti; Janne-Maree Blackman; Neil Catford; Peter Stockton
Journal:  Community Ment Health J       Date:  2004-10

7.  Coping with psychosis: an integrative developmental framework.

Authors:  David Roe; Philip T Yanos; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2006-12       Impact factor: 2.254

8.  Posttraumatic Growth in Psychosis.

Authors:  Yael Mazor; Marc Gelkopf; Kim T Mueser; David Roe
Journal:  Front Psychiatry       Date:  2016-12-19       Impact factor: 4.157

9.  Executive function does not predict coping with symptoms in stable patients with a diagnosis of schizophrenia.

Authors:  Maarten Bak; Lydia Krabbendam; Philippe Delespaul; Karola Huistra; Wil Walraven; Jim van Os
Journal:  BMC Psychiatry       Date:  2008-05-29       Impact factor: 3.630

10.  Qualitative investigation of targets for and barriers to interventions to prevent psychosis relapse.

Authors:  Emily Eisner; Christine Barrowclough; Fiona Lobban; Richard Drake
Journal:  BMC Psychiatry       Date:  2014-07-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.